10/18/2024

Janusmed sex and gender

Janusmed sex and gender – doxycycline hyclate

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Doxycycline

Doxycycline

Class : A

Show all info

Print

Contact us

  1. Binh VQ, Chinh NT, Thanh NX, Cuong BT, Quang NN, Dai B et al. Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects. Am J Trop Med Hyg. 2009;81:747-53.

  2. Food and Drug Administration (FDA). Clinical Pharmacology and Biopharmaceutics Review - PERIOSTAT (doxycycline). Food and Drug Administration [www]. [updated 2001-02-02, cited 2016-01-21].

  3. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29:497-502.

  4. Del Rosso JQ, Preston NJ, Caveney SW, Gottschalk RW. Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender. J Drugs Dermatol. 2012;11:703-7.

  5. Vibramycin (doxycyline). DailyMed [www]. US National Library of Medicine. [updated 2015-05-01, cited 2016-01-21].

  6. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29-37.

  7. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-06-30.]

  1. Binh VQ, Chinh NT, Thanh NX, Cuong BT, Quang NN, Dai B et al. Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects. Am J Trop Med Hyg. 2009;81:747-53.
  2. Food and Drug Administration (FDA). Clinical Pharmacology and Biopharmaceutics Review - PERIOSTAT (doxycycline). Food and Drug Administration [www]. [updated 2001-02-02, cited 2016-01-21].
  3. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29:497-502.
  4. Del Rosso JQ, Preston NJ, Caveney SW, Gottschalk RW. Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender. J Drugs Dermatol. 2012;11:703-7.
  5. Vibramycin (doxycyline). DailyMed [www]. US National Library of Medicine. [updated 2015-05-01, cited 2016-01-21].
  6. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29-37.
  7. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-06-30.]